The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Migraine-Global Market Insights and Sales Trends 2024
Synopsis
A migraine is a primary headache disorder characterized by recurrent headaches that are moderate to severe. Typically, the headaches affect one half of the head, are pulsating in nature, and last from two to 72 hours. Associated symptoms may include nausea, vomiting, and sensitivity to light, sound, or smell. The pain is generally made worse by physical activity.
The global Migraine market size is expected to reach US$ 9237.6 million by 2029, growing at a CAGR of 8.2% from 2023 to 2029. The market is mainly driven by the significant applications of Migraine in various end use industries. The expanding demands from the Hospitals, Clinics and Home Care,, are propelling Migraine market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injectable segment is estimated at % CAGR for the next seven-year period.
Globally, approximately 15% of people are affected by migraines. It most often starts at puberty and is worst during middle age. As of 2016 migraines is one of the most common causes of disability.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Migraine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Migraine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Migraine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Migraine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Migraine covered in this report include Pfizer, GlaxoSmithKline, Allergan, Amgen, Eli Lilly, Teva Pharma, Biohaven Pharma, Abbott Laboratories and Johnson & Johnson, etc.
The global Migraine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
GlaxoSmithKline
Allergan
Amgen
Eli Lilly
Teva Pharma
Biohaven Pharma
Abbott Laboratories
Johnson & Johnson
Valeant Pharma
Global Migraine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Migraine market, Segment by Type:
Oral
Injectable
Nasal Sprays
Others
Global Migraine market, by Application
Hospitals
Clinics
Home Care
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Migraine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
A migraine is a primary headache disorder characterized by recurrent headaches that are moderate to severe. Typically, the headaches affect one half of the head, are pulsating in nature, and last from two to 72 hours. Associated symptoms may include nausea, vomiting, and sensitivity to light, sound, or smell. The pain is generally made worse by physical activity.
The global Migraine market size is expected to reach US$ 9237.6 million by 2029, growing at a CAGR of 8.2% from 2023 to 2029. The market is mainly driven by the significant applications of Migraine in various end use industries. The expanding demands from the Hospitals, Clinics and Home Care,, are propelling Migraine market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injectable segment is estimated at % CAGR for the next seven-year period.
Globally, approximately 15% of people are affected by migraines. It most often starts at puberty and is worst during middle age. As of 2016 migraines is one of the most common causes of disability.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Migraine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Migraine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Migraine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Migraine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Migraine covered in this report include Pfizer, GlaxoSmithKline, Allergan, Amgen, Eli Lilly, Teva Pharma, Biohaven Pharma, Abbott Laboratories and Johnson & Johnson, etc.
The global Migraine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
GlaxoSmithKline
Allergan
Amgen
Eli Lilly
Teva Pharma
Biohaven Pharma
Abbott Laboratories
Johnson & Johnson
Valeant Pharma
Global Migraine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Migraine market, Segment by Type:
Oral
Injectable
Nasal Sprays
Others
Global Migraine market, by Application
Hospitals
Clinics
Home Care
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Migraine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Migraine
1.1 Migraine Market Overview
1.1.1 Migraine Product Scope
1.1.2 Migraine Market Status and Outlook
1.2 Global Migraine Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Migraine Market Size by Region (2018-2029)
1.4 Global Migraine Historic Market Size by Region (2018-2023)
1.5 Global Migraine Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Migraine Market Size (2018-2029)
1.6.1 North America Migraine Market Size (2018-2029)
1.6.2 Europe Migraine Market Size (2018-2029)
1.6.3 Asia-Pacific Migraine Market Size (2018-2029)
1.6.4 Latin America Migraine Market Size (2018-2029)
1.6.5 Middle East & Africa Migraine Market Size (2018-2029)
2 Migraine Market by Type
2.1 Introduction
2.1.1 Oral
2.1.2 Injectable
2.1.3 Nasal Sprays
2.1.4 Others
2.2 Global Migraine Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Migraine Historic Market Size by Type (2018-2023)
2.2.2 Global Migraine Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Migraine Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Migraine Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Migraine Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Migraine Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Migraine Revenue Breakdown by Type (2018-2029)
3 Migraine Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Home Care
3.2 Global Migraine Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Migraine Historic Market Size by Application (2018-2023)
3.2.2 Global Migraine Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Migraine Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Migraine Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Migraine Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Migraine Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Migraine Revenue Breakdown by Application (2018-2029)
4 Migraine Competition Analysis by Players
4.1 Global Migraine Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Migraine as of 2022)
4.3 Date of Key Players Enter into Migraine Market
4.4 Global Top Players Migraine Headquarters and Area Served
4.5 Key Players Migraine Product Solution and Service
4.6 Competitive Status
4.6.1 Migraine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Migraine Products, Services and Solutions
5.1.4 Pfizer Migraine Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 GlaxoSmithKline
5.2.1 GlaxoSmithKline Profile
5.2.2 GlaxoSmithKline Main Business
5.2.3 GlaxoSmithKline Migraine Products, Services and Solutions
5.2.4 GlaxoSmithKline Migraine Revenue (US$ Million) & (2018-2023)
5.2.5 GlaxoSmithKline Recent Developments
5.3 Allergan
5.3.1 Allergan Profile
5.3.2 Allergan Main Business
5.3.3 Allergan Migraine Products, Services and Solutions
5.3.4 Allergan Migraine Revenue (US$ Million) & (2018-2023)
5.3.5 Amgen Recent Developments
5.4 Amgen
5.4.1 Amgen Profile
5.4.2 Amgen Main Business
5.4.3 Amgen Migraine Products, Services and Solutions
5.4.4 Amgen Migraine Revenue (US$ Million) & (2018-2023)
5.4.5 Amgen Recent Developments
5.5 Eli Lilly
5.5.1 Eli Lilly Profile
5.5.2 Eli Lilly Main Business
5.5.3 Eli Lilly Migraine Products, Services and Solutions
5.5.4 Eli Lilly Migraine Revenue (US$ Million) & (2018-2023)
5.5.5 Eli Lilly Recent Developments
5.6 Teva Pharma
5.6.1 Teva Pharma Profile
5.6.2 Teva Pharma Main Business
5.6.3 Teva Pharma Migraine Products, Services and Solutions
5.6.4 Teva Pharma Migraine Revenue (US$ Million) & (2018-2023)
5.6.5 Teva Pharma Recent Developments
5.7 Biohaven Pharma
5.7.1 Biohaven Pharma Profile
5.7.2 Biohaven Pharma Main Business
5.7.3 Biohaven Pharma Migraine Products, Services and Solutions
5.7.4 Biohaven Pharma Migraine Revenue (US$ Million) & (2018-2023)
5.7.5 Biohaven Pharma Recent Developments
5.8 Abbott Laboratories
5.8.1 Abbott Laboratories Profile
5.8.2 Abbott Laboratories Main Business
5.8.3 Abbott Laboratories Migraine Products, Services and Solutions
5.8.4 Abbott Laboratories Migraine Revenue (US$ Million) & (2018-2023)
5.8.5 Abbott Laboratories Recent Developments
5.9 Johnson & Johnson
5.9.1 Johnson & Johnson Profile
5.9.2 Johnson & Johnson Main Business
5.9.3 Johnson & Johnson Migraine Products, Services and Solutions
5.9.4 Johnson & Johnson Migraine Revenue (US$ Million) & (2018-2023)
5.9.5 Johnson & Johnson Recent Developments
5.10 Valeant Pharma
5.10.1 Valeant Pharma Profile
5.10.2 Valeant Pharma Main Business
5.10.3 Valeant Pharma Migraine Products, Services and Solutions
5.10.4 Valeant Pharma Migraine Revenue (US$ Million) & (2018-2023)
5.10.5 Valeant Pharma Recent Developments
6 North America
6.1 North America Migraine Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Migraine Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Migraine Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Migraine Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Migraine Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Migraine Market Dynamics
11.1 Migraine Industry Trends
11.2 Migraine Market Drivers
11.3 Migraine Market Challenges
11.4 Migraine Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
